Search for: "ML " Results 601 - 620 of 2,749
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Mar 2021, 7:12 am by Laura Ray
Several of the eighteen Law Library Legal Research Seminars demonstrate research in a social justice topic and cost-effective research strategies: Starting Research with Secondary Sources Terms & Connectors Searching Cost-Effective Searching on Lexis & Westlaw Cost-Effective Federal Legislative History: Congress.gov and Govinfo.gov Law Library Legal Research Seminars are for C|M|LAW students, including MLS and LLM students, and are continuously available online via the Westlaw TWEN… [read post]
4 Mar 2021, 8:50 pm by Simon Lovegrove (UK)
On 3 March 2021, the European Banking Authority (EBA) published its biennial opinion on risks of money laundering and terrorist financing (ML/TF) affecting the EU’s financial sector. [read post]
22 Feb 2021, 2:53 am by Robbie Stern
The High Court ruled that a Court should exercise “very considerable caution” when asked  to admit and to evaluate evidence relating  to an alleged breach of an assurance given to a foreign authority or court [38], for two reasons: In ML v Hungary C-220/18 PPU, the CJEU had emphasised that the task of the executing judicial authority was to assess “solely the actual and precise conditions of detention of the person concerned”. [read post]
19 Feb 2021, 2:30 pm by Rebecca Tushnet
Jeanne Fromer & Barton Beebe, NYU School of Law The Future of Trademark Depletion in a Global, Multilingual Economy: Evidence and Lessons from the European Union TMs transcend boundaries b/c brands transcend boundaries; even small businesses are often looking beyond borders to other countries. [read post]
18 Feb 2021, 3:32 pm by Rebecca Tushnet
Liza Vertinsky, Emory University School of Law Artificial Intelligence, Patents and Competition Thesis: ML along with control over large data sets will end up increasing concentration of and control over innovation processes in ways our current regulatory system is not equipped to deal with. [read post]
18 Feb 2021, 3:31 pm by News Desk
Use a kitchen sanitizer (following the directions on the container) or a bleach solution (5 mL household bleach to 750 mL of water), and rinse with water. [read post]
18 Feb 2021, 6:47 am by Kevin Kaufman
Richard Lindsay (D), would increase taxes on liquid used in vapor products from 7.5 cents per milliliter (ml) to $1 per ml—an increase of over 1,300 percent. [read post]
15 Feb 2021, 10:00 pm
Our FDA team recently published an Insight covering key considerations for artificial intelligence (AI) healthcare application developers and users, highlighting the FDA’s current regulatory scheme for AI/machine learning (ML)-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
15 Feb 2021, 10:00 pm
Our FDA team recently published an Insight covering key considerations for artificial intelligence (AI) healthcare application developers and users, highlighting the FDA’s current regulatory scheme for AI/machine learning (ML)-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
15 Feb 2021, 10:00 pm
Our FDA team recently published an Insight covering key considerations for artificial intelligence (AI) healthcare application developers and users, highlighting the FDA’s current regulatory scheme for AI/machine learning (ML)-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
15 Feb 2021, 10:00 pm
Our FDA team recently published an Insight covering key considerations for artificial intelligence (AI) healthcare application developers and users, highlighting the FDA’s current regulatory scheme for AI/machine learning (ML)-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
15 Feb 2021, 10:00 pm
Our FDA team recently published an Insight covering key considerations for artificial intelligence (AI) healthcare application developers and users, highlighting the FDA’s current regulatory scheme for AI/machine learning (ML)-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
15 Feb 2021, 10:00 pm
Our FDA team recently published an Insight covering key considerations for artificial intelligence (AI) healthcare application developers and users, highlighting the FDA’s current regulatory scheme for AI/machine learning (ML)-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
Since 2014, the Financial Action Task Force (FATF), an intergovernmental organization which set international standards for anti-money laundering and counter-terrorist financing (AML/CTF), has published reports as well as guidance on ML/TF risks and red flag indicators for identifying suspicious ML/TF activity in connection with virtual assets service providers (VASPs) and setting the minimum AML/CTF standards for the sector. [read post]
9 Feb 2021, 5:40 pm by Dan Bressler
” “One of the key areas of non-compliance with the ML Regs identified by the SRA is the requirement to independently audit the firm’s PCPs. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]
31 Jan 2021, 10:00 pm
Here we highlight FDA’s current regulatory scheme for AI/ML-based software, potential FDA enforcement discretion that may apply, and recent FDA developments impacting AI/ML technologies. [read post]